116 related articles for article (PubMed ID: 16353238)
21. Nobiletin protects dopaminergic neurons in the 1-methyl-4-phenylpyridinium-treated rat model of Parkinson's disease.
Jeong KH; Jeon MT; Kim HD; Jung UJ; Jang MC; Chu JW; Yang SJ; Choi IY; Choi MS; Kim SR
J Med Food; 2015 Apr; 18(4):409-14. PubMed ID: 25325362
[TBL] [Abstract][Full Text] [Related]
22. Secalonic acid A protects dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP⁺)-induced cell death via the mitochondrial apoptotic pathway.
Zhai A; Zhu X; Wang X; Chen R; Wang H
Eur J Pharmacol; 2013 Aug; 713(1-3):58-67. PubMed ID: 23665112
[TBL] [Abstract][Full Text] [Related]
23. Impaired acquisition of skilled behavior in rotarod task by moderate depletion of striatal dopamine in a pre-symptomatic stage model of Parkinson's disease.
Ogura T; Ogata M; Akita H; Jitsuki S; Akiba L; Noda K; Hoka S; Saji M
Neurosci Res; 2005 Mar; 51(3):299-308. PubMed ID: 15710494
[TBL] [Abstract][Full Text] [Related]
24. Melatonin protects nigral dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity in rats.
Jin BK; Shin DY; Jeong MY; Gwag MR; Baik HW; Yoon KS; Cho YH; Joo WS; Kim YS; Baik HH
Neurosci Lett; 1998 Apr; 245(2):61-4. PubMed ID: 9605485
[TBL] [Abstract][Full Text] [Related]
25. Mangiferin protects against 1-methyl-4-phenylpyridinium toxicity mediated by oxidative stress in N2A cells.
Amazzal L; Lapôtre A; Quignon F; Bagrel D
Neurosci Lett; 2007 May; 418(2):159-64. PubMed ID: 17433543
[TBL] [Abstract][Full Text] [Related]
26. Roles of autophagy in MPP+-induced neurotoxicity in vivo: the involvement of mitochondria and α-synuclein aggregation.
Hung KC; Huang HJ; Lin MW; Lei YP; Lin AM
PLoS One; 2014; 9(3):e91074. PubMed ID: 24646838
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the effect of adenoviral delivery of three superoxide dismutase genes against hepatic ischemia-reperfusion injury.
Wheeler MD; Katuna M; Smutney OM; Froh M; Dikalova A; Mason RP; Samulski RJ; Thurman RG
Hum Gene Ther; 2001 Dec; 12(18):2167-77. PubMed ID: 11779401
[TBL] [Abstract][Full Text] [Related]
28. MPP+-induced neuronal death in rats involves tyrosine 33 phosphorylation of WW domain-containing oxidoreductase WOX1.
Lo CP; Hsu LJ; Li MY; Hsu SY; Chuang JI; Tsai MS; Lin SR; Chang NS; Chen ST
Eur J Neurosci; 2008 Apr; 27(7):1634-46. PubMed ID: 18371080
[TBL] [Abstract][Full Text] [Related]
29. Naringin protects the nigrostriatal dopaminergic projection through induction of GDNF in a neurotoxin model of Parkinson's disease.
Leem E; Nam JH; Jeon MT; Shin WH; Won SY; Park SJ; Choi MS; Jin BK; Jung UJ; Kim SR
J Nutr Biochem; 2014 Jul; 25(7):801-6. PubMed ID: 24797334
[TBL] [Abstract][Full Text] [Related]
30. Methylparaben protects 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells and improved behavioral impairments in mouse model of Parkinson's disease.
Kopalli SR; Noh SJ; Koppula S; Suh YH
Neurotoxicology; 2013 Jan; 34():25-32. PubMed ID: 23068419
[TBL] [Abstract][Full Text] [Related]
31. Trichloroethylene exposure aggravates behavioral abnormalities in mice that are deficient in superoxide dismutase.
Otsuki N; Homma T; Fujiwara H; Kaneko K; Hozumi Y; Shichiri M; Takashima M; Ito J; Konno T; Kurahashi T; Yoshida Y; Goto K; Fujii S; Fujii J
Regul Toxicol Pharmacol; 2016 Aug; 79():83-90. PubMed ID: 27166294
[TBL] [Abstract][Full Text] [Related]
32. Melatonin attenuates MPP+-induced neurodegeneration and glutathione impairment in the nigrostriatal dopaminergic pathway.
Chen ST; Chuang JI; Hong MH; Li EI
J Pineal Res; 2002 May; 32(4):262-9. PubMed ID: 11982797
[TBL] [Abstract][Full Text] [Related]
33. Efficient in vivo protection of nigral dopaminergic neurons by lentiviral gene transfer of a modified Neurturin construct.
Fjord-Larsen L; Johansen JL; Kusk P; Tornøe J; Grønborg M; Rosenblad C; Wahlberg LU
Exp Neurol; 2005 Sep; 195(1):49-60. PubMed ID: 15919076
[TBL] [Abstract][Full Text] [Related]
34. 7-nitroindazole protects striatal dopaminergic neurons against MPP+-induced degeneration: an in vivo microdialysis study.
Di Matteo V; Benigno A; Pierucci M; Giuliano DA; Crescimanno G; Esposito E; Di Giovanni G
Ann N Y Acad Sci; 2006 Nov; 1089():462-71. PubMed ID: 17261789
[TBL] [Abstract][Full Text] [Related]
35. Role of L-thyroxin in counteracting rotenone induced neurotoxicity in rats.
Salama M; Helmy B; El-Gamal M; Reda A; Ellaithy A; Tantawy D; Mohamed M; El-Gamal A; Sheashaa H; Sobh M
Environ Toxicol Pharmacol; 2013 Mar; 35(2):270-7. PubMed ID: 23357603
[TBL] [Abstract][Full Text] [Related]
36. Lack of robust protective effect of quercetin in two types of 6-hydroxydopamine-induced parkinsonian models in rats and dopaminergic cell cultures.
Kääriäinen TM; Piltonen M; Ossola B; Kekki H; Lehtonen S; Nenonen T; Lecklin A; Raasmaja A; Männistö PT
Brain Res; 2008 Apr; 1203():149-59. PubMed ID: 18329008
[TBL] [Abstract][Full Text] [Related]
37. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
Saravanan KS; Sindhu KM; Senthilkumar KS; Mohanakumar KP
Neurochem Int; 2006 Jul; 49(1):28-40. PubMed ID: 16490285
[TBL] [Abstract][Full Text] [Related]
38. Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice.
Iancu R; Mohapel P; Brundin P; Paul G
Behav Brain Res; 2005 Jul; 162(1):1-10. PubMed ID: 15922062
[TBL] [Abstract][Full Text] [Related]
39. 17Beta-estradiol reduces nitrotyrosine immunoreactivity and increases SOD1 and SOD2 immunoreactivity in nigral neurons in male mice following MPTP insult.
Tripanichkul W; Sripanichkulchai K; Duce JA; Finkelstein DI
Brain Res; 2007 Aug; 1164():24-31. PubMed ID: 17640623
[TBL] [Abstract][Full Text] [Related]
40. Neuroprotective effects of neurokinin receptor one in dopaminergic neurons are mediated through Akt/PKB cell signaling pathway.
Chu JM; Chen LW; Chan YS; Yung KK
Neuropharmacology; 2011 Dec; 61(8):1389-98. PubMed ID: 21907219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
